1 research outputs found
Additional file 1: Table S1. of Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
Metabolic response evaluated by PET-scan Description: Global metabolic response evaluated by PET-scan at day 15, or at day 15 and 56 as compared to baseline and patients’ status at 2.8 months. R: Responder; NR: Non Responder. (DOCX 25 kb